Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. - sprookjes - yvandenbroek - TriplyDB

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

http://www.wikidata.org/entity/Q34005065

about

The role of indoor allergens in the development of asthma Allergen-specific immunotherapy in pediatric allergic asthma United airway disease: current perspectives Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future A systematic review of predictive models for asthma development in children Clinical practice. Allergic rhinitis Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy Recombinant allergens: the present and the future New vaccines for Mammalian allergy using molecular approaches Role of immunotherapy in the treatment of allergic asthma The Danish National Database for Asthma: establishing clinical quality indicators Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy agein Therapeutic interventions in severe asthma International consensus on (ICON) pediatric asthma EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy.Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.Sublingual immunotherapy: World Allergy Organization position paper 2013 update.Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews.Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax(®)) in children Strategies of mucosal immunotherapy for allergic diseases Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children Utility of the Asthma Predictive Index in predicting childhood asthma and identifying disease-modifying interventions.Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation.Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence.Asthma: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations.Asthma-related comorbidities.Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.Patients' compliance with different administration routes for allergen immunotherapy in Germany.Clinical practice guideline: Allergic rhinitis.Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.Allergic airway diseases in a tropical urban environment are driven by dominant mono-specific sensitization against house dust mites.Regulatory T cells in many flavors control asthma SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma.Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.The need for patient-focused therapy for children and teenagers with allergic rhinitis: a case-based review of current European practice Early detection of allergic diseases in otorhinolaryngology Prospective adherence to specific immunotherapy in Europe (PASTE) survey protocol."The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis".Early identification of atopy in the prediction of persistent asthma in children

P2860

Q24653862-86F0F403-8AF3-4DB8-977F-C9239E43619A Q26739254-6BFA9566-70CA-455A-9DED-6E923190DEF3 Q26743436-59352B51-72ED-4BF7-8056-0ED61B980760 Q26768511-040C04F3-5F0D-453E-9CB5-0FDB29F7983B Q26776289-E0B3CACB-B32A-4102-B9B5-725222F8343F Q26822043-DEB47A45-7E7D-40C2-A3ED-18928F7B5325 Q26852113-13E720D0-2354-4735-BA43-C714EF48451F Q26996701-268D2E93-1125-4F57-BC2C-EC8CD82EE8F8 Q26998820-3F66D47B-DEF5-4957-9E8A-E7A31AE57F51 Q27021489-0A3E80A1-339F-4952-A429-E0C6068BF988 Q28074257-10CAFA56-D669-43B4-946D-0257AB59FB84 Q28077951-04D8AB62-4ADB-4FF0-8194-BE9C734F8560 Q28079238-6354B5FA-70C3-4590-9E0C-4281BF7C91D6 Q30393965-D1F7DB5A-211E-4B02-A030-18B6356AC6A7 Q30394524-8ADB25AF-D333-4ED4-B11F-A581DEA81EBD Q30402227-8B4AB0C3-E039-4857-B3BD-A853A8C3D363 Q30440195-B4236C38-AC88-415D-9BB0-69894469FBB9 Q31030974-5A9A57DA-BFF1-4242-A10B-8C49C3223B5A Q33573199-929931C2-00E9-46E7-8A42-D7E9ED987263 Q33577679-1F61D3CF-BBD9-44B3-8201-29D9766F8E70 Q33586188-D925EFC5-F691-4863-9F98-C7BCF26650BD Q33606510-814D1125-FCB6-459B-A306-24D348A3230B Q33752348-0AEAA4DF-8064-4A9D-B40E-883B088C877C Q33802263-78428596-E244-4B12-ACED-2F5311468BC6 Q33956813-80A36D17-D6E9-40AD-8698-E7FEB12FD0C8 Q34003337-246EF87E-998C-41A3-B4A5-90FADFA0E294 Q34195201-065C67B4-CEEC-424B-90C6-6E8594B34CFC Q34402672-1D347C2B-3DFE-4FF1-8927-FA887632AFC5 Q34434850-77A3F84D-8C5C-4AE5-A78F-12A914CEDA65 Q34460983-CCB885D1-ACC6-43C0-9A4B-DD542C1851D1 Q34527154-712426E7-C5C5-474C-B46A-2D36E14D1331 Q34556674-18E07325-46FC-4029-94B3-1D91096B11D2 Q34574231-A666468E-8348-4889-9C22-B9E078E281D1 Q34577305-5F527B90-BDCE-4D81-8582-5BD9F6B4958B Q34625206-349315A7-26E3-428B-9F5C-8FD2E6D34C5C Q35052674-8C2FB836-CB12-40C6-A5D1-82F1DF0A477D Q35427549-DAB8C1B1-78F2-429B-BE6D-CD529998D559 Q35540640-4E111174-4230-4346-BA61-045F3D6FB214 Q35564301-BAB42D9A-2443-4395-914C-C845D85E3077 Q35633553-09AB6270-AD1B-4AB9-8386-E5312C3F20D0

P2860

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.

http://www.wikidata.org/entity/Q34005065

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@ast

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@en

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@nl

type

label

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@ast

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@en

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@nl

prefLabel

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@ast

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@en

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@nl

P1433

Q34005065-B0EED205-9296-4EDB-8529-BD128DDF7136

P1476

Q34005065-A7B30C50-B22A-4572-8045-8B70DF7AF2CF

P2093

Q34005065-0CFCB8E7-2B7D-4E9A-9269-DBF1248AD1CB

Q34005065-155362DD-40AE-4F3B-9144-6B352934EA86

Q34005065-9181D750-085A-48E6-A7EE-28D592CC0BF3

Q34005065-A0A6AF38-26BE-4CB4-AF5A-99985BF6BEDC

Q34005065-BA48B010-CBD1-400D-B131-6B77E6D0FF1F

Q34005065-D9F86B1B-C358-40D6-8915-028DD8898385

Q34005065-DC36377E-F144-426E-821F-3262D1762C90

Q34005065-E028F292-DB5D-4451-A7A5-DAEE554B97C9

Q34005065-E0ACA5E8-F6A6-45F9-AEC1-48C5FDE6E9B8

Q34005065-E1949F9E-5959-46B0-9F91-ED33F912BCE3

P2860

Q34005065-07B342D7-297A-498A-8AB0-DDAA81D9E3B0

Q34005065-2B577CA1-CD71-4AA4-A298-BEA1A66C435B

Q34005065-323D651D-7D7B-4984-9C3A-1898F2C4079E

Q34005065-3FE1C416-F585-437E-8D28-F8709A365B33

Q34005065-483DB3B4-F2B5-4198-93C6-67E9859B6222

Q34005065-65CA10F4-C28E-4DD2-A10E-FCFFE30CDBF4

Q34005065-A0F64113-BB07-435C-BAB2-70B04D9044FD

Q34005065-B3451508-00E5-47A4-BD71-A276789D6298

Q34005065-C8EB4547-2B78-4742-8B8A-8DC8945B3FC4

Q34005065-D7065EA7-F425-4C7B-B29D-993753B443EF

P304

Q34005065-2849B886-8AD8-417C-8C42-1A74AF377BFE

P31

Q34005065-C99D1B49-1D2A-447E-8DD5-3B0C8C0613C2

P356

Q34005065-14E9DF69-C107-4F55-9511-78C49CAE4934

P433

Q34005065-65431522-711A-476B-949C-BDA2CDD9FAFE

P478

Q34005065-0CEE9B3C-D25D-4871-93CA-6DFBFE0299E3

P577

Q34005065-C7BBCB2D-5024-4560-B10D-6D05326836E9

P5875

Q34005065-16BEED17-0354-4008-B723-B4AB1B03D347

P698

Q34005065-C869417A-929F-49FC-A6D6-95C19F21FFBF

P921

Q34005065-0D665F0E-7484-4C82-BC0C-09F6E4915662

Q34005065-36460A4B-A432-49E5-A884-4D86430C0FF3

P356

J.1398-9995.2007.01451.X

P1433

P1476

Specific immunotherapy has lon ...... ar follow-up on the PAT study.

@en

P2093

(The PAT investigator group)

http://www.w3.org/2001/XMLSchema#string

A Høst

http://www.w3.org/2001/XMLSchema#string

A Koivikko

http://www.w3.org/2001/XMLSchema#string

B Niggemann

http://www.w3.org/2001/XMLSchema#string

C Möller

http://www.w3.org/2001/XMLSchema#string

E Valovirta

http://www.w3.org/2001/XMLSchema#string

H A Ferdousi

http://www.w3.org/2001/XMLSchema#string

L A Norberg

http://www.w3.org/2001/XMLSchema#string

L Jacobsen

http://www.w3.org/2001/XMLSchema#string

S Dreborg

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiologic evidence for asthma and rhinitis comorbidity.

Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study

Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC).

Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.

Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood.

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

The precision of the conjunctival provocation test.

Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years.

Rhinitis as an independent risk factor for adult-onset asthma.

P304

943-948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1398-9995.2007.01451.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6217994

http://www.w3.org/2001/XMLSchema#string

P698

17620073

http://www.w3.org/2001/XMLSchema#string

P921